Evidence map›Paper›PMID 41083908›Full record

ArticleThe EMBO journal2025

Control of flagellar gene expression by a chemotaxis receptor-like regulator in pathogenic Escherichia coli.

Jae-Woo Lee, Liyun Wang, Sarah L Comer, Remy Colin, Mollie M Gidney, Leanid Laganenka, Wolf-Dietrich Hardt, Maria Hadjifrangiskou, Victor Sourjik

Abstract read
In one paragraph

Article in The EMBO journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Jae-Woo Lee *Max Planck Institute for Terrestrial Microbiology and Center for Synthetic Microbiology (SYNMIKRO), Marburg, Germany.
Liyun Wang *Max Planck Institute for Terrestrial Microbiology and Center for Synthetic Microbiology (SYNMIKRO), Marburg, Germany.ORCID http://orcid.org/0000-0002-3123-7727
Sarah L ComerDepartment of Pathology, Microbiology & Immunology, Vanderbilt University Medical Center, Nashville, TN, USA.
Remy ColinMax Planck Institute for Terrestrial Microbiology and Center for Synthetic Microbiology (SYNMIKRO), Marburg, Germany.
Mollie M GidneyDepartment of Pathology, Microbiology & Immunology, Vanderbilt University Medical Center, Nashville, TN, USA.
Leanid LaganenkaInstitute of Microbiology, D-BIOL, ETH Zurich, Zurich, Switzerland.
Wolf-Dietrich HardtInstitute of Microbiology, D-BIOL, ETH Zurich, Zurich, Switzerland.
Maria HadjifrangiskouDepartment of Pathology, Microbiology & Immunology, Vanderbilt University Medical Center, Nashville, TN, USA.ORCID http://orcid.org/0000-0003-4249-8997
Victor SourjikMax Planck Institute for Terrestrial Microbiology and Center for Synthetic Microbiology (SYNMIKRO), Marburg, Germany. victor.sourjik@mpi-marburg.mpg.de.ORCID http://orcid.org/0000-0003-1053-9192

Funding

Chemical Biology of Infectious Diseases (CBID) Training ProgramT32AI112541 · NIAID · VANDERBILT UNIVERSITY · PI Eric P Skaar · 2015 to 2026
$4.0M
How E. coli Acid Response Mechanisms Breach Colonization Resistance in the VaginaR01AI168468 · NIAID · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Maria Hadjifrangiskou · 2022 to 2026
$2.9M
Targeting cytochrome bd as an anti-biofilm strategyR21AI175788 · NIAID · VANDERBILT UNIVERSITY MEDICAL CENTER · PI HADJIFRANGISKOU, MARIA · 2023 to 2024
$489k
Deutsche Forschungsgemeinschaft (DFG) LA 22 4572/1-1HHS | National Institutes of Health (NIH) 1R21AI175788-01HHS | National Institutes of Health (NIH) NIH-NIAID- 5T32AI112541-08HHS | National Institutes of Health (NIH) R01 AI168468-01National Research Foundation of Korea (NRF) NRF-2019R1A6A3A0303 1885NIAID NIH HHS R01 AI168468NIAID NIH HHS R21 AI175788NIAID NIH HHS T32 AI112541Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (SNF) 100.001.588Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (SNF) 51NF40_180575
6 · The paper itself

Abstract

Chemoreceptors enable bacteria to modulate their swimming behavior in response to the perceived environmental cues. Despite the large diversity of stimuli sensed by bacterial chemoreceptors, their output to the chemotaxis pathway that controls the flagellar motor typically converges on a few conserved signaling proteins. Here, we characterize a unique chemoreceptor-like protein, Tls, which is found in the B2 phylogroup of Escherichia coli that includes many extraintestinal pathogenic (ExPEC) strains. Instead of mediating chemotactic signaling, Tls controls motility by repressing the expression of flagellar genes, and thus cell motility, through sequestration of the transcriptional master activator of flagellar genes, FlhDC. The subcellular localization of Tls, the sequestration of FlhDC, and the repression of flagellar gene expression and motility are all abolished during growth on porous medium, indicating that this regulation may be mechanosensitive. Deletion of tls in a uropathogenic E. coli strain leads to reduced attachment to the urinary tract cells and an increased migration to and/or proliferation in the murine gut, a pathogen reservoir niche, thus implicating Tls in the regulation of motility during infection.

Indexed as

ChemotaxisEscherichia coliEscherichia coli ProteinsFlagellaGene Expression Regulation, BacterialAnimalsEscherichia coli InfectionsMiceTrans-ActivatorsEscherichia coli ProteinsTrans-ActivatorsBacteriaChemotaxisMechanosensingMotilityReceptorsVirulence

Identifiers

PMID41083908
PMCPMC12623472

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.